{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:10:08Z","timestamp":1744117808007,"version":"3.40.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07223-1","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:33:41Z","timestamp":1744115621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paradigm shift in age of multiple myeloma patients: a study from a tertiary care government oncology hospital in Pakistan"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8211-4639","authenticated-orcid":false,"given":"Maryam","family":"Habib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wardah","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeeda","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"4","key":"7223_CR1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cll.2017.08.001","volume":"37","author":"KT Soh","year":"2017","unstructured":"Soh KT, Tario JD Jr, Wallace PK. Diagnosis of plasma cell dyscrasias and monitoring of minimal residual disease by multiparametric flow cytometry. Clin Lab Med. 2017;37(4):821\u201353. https:\/\/doi.org\/10.1016\/j.cll.2017.08.001.","journal-title":"Clin Lab Med"},{"issue":"10","key":"7223_CR2","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3324\/haematol.2020.24701","volume":"105","author":"A Gulla","year":"2020","unstructured":"Gulla A, Anderson KC. Multiple myeloma: the (r)evolution of current therapy and a glance into future. Haematologica. 2020;105(10):2358\u201367. https:\/\/doi.org\/10.3324\/haematol.2020.24701.","journal-title":"Haematologica"},{"issue":"5","key":"7223_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464\u201377. https:\/\/doi.org\/10.1001\/jama.2022.0003.","journal-title":"JAMA"},{"key":"7223_CR4","doi-asserted-by":"publisher","first-page":"117822421986823","DOI":"10.1177\/1178224219868235","volume":"13","author":"SA Bird","year":"2019","unstructured":"Bird SA, Boyd K. Multiple myeloma: an overview of management. Palliat Care Soc Pract. 2019;13:1178224219868235. https:\/\/doi.org\/10.1177\/1178224219868235.","journal-title":"Palliat Care Soc Pract"},{"issue":"1","key":"7223_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajcp\/aqw143","volume":"147","author":"KA Fleming","year":"2017","unstructured":"Fleming KA, Naidoo M, Wilson M, et al. An essential pathology package for low- and middle-income countries. Am J Clin Pathol. 2017;147(1):15\u201332. https:\/\/doi.org\/10.1093\/ajcp\/aqw143.","journal-title":"Am J Clin Pathol"},{"key":"7223_CR6","unstructured":"SEER Cancer stat fact sheets: myeloma. (2021) National Institutes of Health, National Cancer Institute Surveillance, Epidemiology, and End Results Program. Available from URL: http:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html. Accessed 27 January 2023."},{"issue":"9","key":"7223_CR7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","volume":"4","author":"AJ Cowan","year":"2018","unstructured":"Cowan AJ, Allen C, Barac A, et al. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol. 2018;4(9):1221\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2128. PubMed: 29800065, PubMed Central: PMC6143021.","journal-title":"JAMA Oncol"},{"issue":"2","key":"7223_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12288-021-01485-y","volume":"38","author":"N Saeed","year":"2022","unstructured":"Saeed N, Ahmad U, Moosajee M, et al. A multicenter study of clinical presentations and outcomes of multiple myeloma in Pakistan: the real-world analysis in a resource-constrained country. Indian J Hematol Blood Transfus. 2022;38(2):309\u201318. https:\/\/doi.org\/10.1007\/s12288-021-01485-y.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"7223_CR9","unstructured":"Cancer Registry - Pakistan Health Research Council. (2020) Available from URL: Phrc.org.pk \u203a cancer-registry. Accessed 10 Dec 2020."},{"key":"7223_CR10","unstructured":"Punjab Cancer Registry. (2020) Available from URL: http:\/\/punjabcancerregistry.org.pk\/index.php. Accessed 10 Dec 2020."},{"key":"7223_CR11","unstructured":"International Association of Cancer Registries-Karachi Cancer Registry. (2020) Available from URL: http:\/\/www.iacr.com.fr\/index.php?option=com_comprofiler%26task=userprofile%26user=1214%26Itemid=498. Accessed 10 Dec 2020."},{"key":"7223_CR12","first-page":"709","volume":"19","author":"A Masood","year":"2018","unstructured":"Masood A, Masood K, Hussain M, et al. Thirty years cancer incidence data for Lahore, Pakistan: trends and patterns 1984\u20132014. Asian Pac J Cancer Prev. 2018;19:709\u201317.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"7223_CR13","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"key":"7223_CR14","doi-asserted-by":"publisher","first-page":"800309","DOI":"10.3389\/fonc.2021.800309","volume":"11","author":"R Alonso","year":"2022","unstructured":"Alonso R, Lahuerta JJ. Tumor reduction in multiple myeloma: new concepts for new therapeutics. Front Oncol. 2022;11:800309. https:\/\/doi.org\/10.3389\/fonc.2021.800309.","journal-title":"Front Oncol"},{"key":"7223_CR15","doi-asserted-by":"publisher","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410\u2013427. https:\/\/doi.org\/10.1016\/S0140-6736(21)00135-5. PubMed: 33516340.","DOI":"10.1016\/S0140-6736(21)00135-5"},{"issue":"3","key":"7223_CR16","first-page":"376","volume":"26","author":"A Basit","year":"2014","unstructured":"Basit A, Siddiqui N, Hameed A, Muzaffar N, Athar S. Factors affecting outcome of patients with multiple myeloma. J Ayub Med Coll Abbottabad. 2014;26(3):376\u20139. PubMed: 25671952.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"7223_CR17","doi-asserted-by":"publisher","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren O. Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin Proc. 2010;85(3):225\u2013230. https:\/\/doi.org\/10.4065\/mcp.2009.0426","DOI":"10.4065\/mcp.2009.0426"},{"key":"7223_CR18","doi-asserted-by":"publisher","unstructured":"Zaheer S, Robert H, Mahmood A, Mahmood R, Khurshid A, Khan N. (2022). Frequency of t(4;14) in multiple myeloma and its Clinicopathological Correlation. Pak Armed Forces Med J. 2022;72(SUPPL-2):S103\u2013S106. https:\/\/doi.org\/10.51253\/pafmj.v72iSUPPL-2.3384","DOI":"10.51253\/pafmj.v72iSUPPL-2.3384"},{"issue":"6","key":"7223_CR19","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1182\/bloodadvances.2021005482","volume":"6","author":"B Kanapuru","year":"2022","unstructured":"Kanapuru B, Fernandes LL, Fashoyin-Aje LA, Baines AC, Bhatnagar V, Ershler R. Analysis of Racial and ethnic disparities in multiple myeloma US FDA drug approval trials. Blood Adv. 2022;6(6):1684\u201391. https:\/\/doi.org\/10.1182\/bloodadvances.2021005482. PubMed: 35114691, PubMed Central: PMC8941450.","journal-title":"Blood Adv"},{"issue":"1","key":"7223_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s42269-022-00926-6","volume":"46","author":"EE Dogan","year":"2022","unstructured":"Dogan EE, Arslan A, Demirel N, et al. Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival. Bull Natl Res Cent. 2022;46(1):242. https:\/\/doi.org\/10.1186\/s42269-022-00926-6.","journal-title":"Bull Natl Res Cent"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07223-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:33:58Z","timestamp":1744115638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07223-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7223"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07223-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol, human ethics and consent to participate was approved by the Ethics Committee and Institutional Review Board of NORI (IRB No.5 [] \/101)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Consent for publication has been obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}